Buy BSX by Dec 23, 2026.

BSX is one of the largest medical-device companies in the world, focused mainly on cardiovascular, endoscopy, urology and neuromodulation. Think catheters, ablation systems, stents, implantable devices and other products used during minimally invasive procedures The stock is around $45 as of September 24, 2026, with a market capitalization of roughly $65B. Trailing P/E around 18x and a forward P/E around 13x. The margins are good, the growth is decent. It's a healthy business (pun intended..) From 2022 to 2025, revenue …